Literature DB >> 20029216

Neuropsychiatric profiles of patients with insulinomas.

Yao Ding1, Shuang Wang, Jianren Liu, Yi Yang, Zhirong Liu, Jufeng Li, Bo Zhang, Ying Chen, Meiping Ding.   

Abstract

BACKGROUND/AIMS: Insulinoma is a rare and potentially curable disease. It is often misdiagnosed as neurological or psychiatric disorder. This study was performed to characterize the neuropsychiatric symptoms (PNS) of the patients with insulinoma from a regional clinical center.
METHODS: All medical records of the patients with histopathologically identified insulinoma were reviewed during the period from 1998 to 2008. A case-control analysis was performed to compare the demographic data, details of clinical presentation, biochemical findings, tumor localization, and intraoperative findings between the patients with and without a prior misdiagnosis.
RESULTS: Among 42 patients with insulinoma, 25 patients with PNS were initially misdiagnosed as having a neurological or psychiatric disease, while 17 patients with no PNS were correctly diagnosed. Most (64%) of PNS cases were not diagnosed correctly until 12 months after the first consultation. In patients with PNS that remained undiagnosed for at least 5 years, the most frequent symptoms were confusion, convulsion, and visual disturbances. Twelve cases of PNS were initially misdiagnosed as epilepsy and 3 of them showed epileptiform discharges on electroencephalography.
CONCLUSIONS: Episodic hypoglycemia induced by insulinoma can greatly mimic neurological and psychiatric presentation. A thorough history taking and inpatient assessment are necessary in evaluating recurrent neurological and psychiatric symptoms. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20029216     DOI: 10.1159/000268166

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

1.  Early detection of cognitive impairment in patients with insulinoma.

Authors:  Hongmei Dai; Hao Chen; Xiafei Hong; Xianlin Han; Qiang Xu; Haiyu Pang; Jing Yuan; Xianze Wang; Peiran Xu; Jialin Jiang; Rui Jiang; Zhe Zhuang; Yupei Zhao; Wenming Wu
Journal:  Endocrine       Date:  2019-07-10       Impact factor: 3.633

2.  Hypersomnia as the first presentation in a patient with insulinoma: A case report and review of the literature.

Authors:  Jiali Pu; Baorong Zhang; Xinzhen Yin
Journal:  Mol Clin Oncol       Date:  2016-07-27

Review 3.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

4.  Radiofrequency Ablation as a Primary Therapy for Benign Functioning Insulinoma.

Authors:  Ebtihal Y Alyusuf; Aishah A Ekhzaimy; Juan A Rivera
Journal:  AACE Clin Case Rep       Date:  2020-12-28

5.  Insulinoma with a History of Epilepsy: Still a Possible Misleading Factor in the Early Diagnosis of Insulinoma.

Authors:  Takaaki Murakami; Takafumi Yamashita; Daisuke Yabe; Toshihiko Masui; Yuki Teramoto; Sachiko Minamiguchi; Keisho Hirota; Masahito Ogura; Kazuaki Nagashima; Nobuya Inagaki
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.